Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Anne C. Bay-Jensen$suffix/text()$suffix/text(), Anne Sofie Siebuhr$suffix/text()$suffix/text(), Dres Damgaard$suffix/text()$suffix/text(), Patryk Drobinski$suffix/text()$suffix/text(), Christian Thudium$suffix/text()$suffix/text(), Joachim Mortensen$suffix/text()$suffix/text() & Claus H Nielsen$suffix/text()$suffix/text(). (2021) Objective and noninvasive biochemical markers in rheumatoid arthritis: where are we and where are we going?. Expert Review of Proteomics 18:3, pages 159-175.
Read now
Read now
Charles J Malemud. (2009) Recent advances in neutralizing the IL-6 pathway in arthritis. Open Access Rheumatology: Research and Reviews 1, pages 133-150.
Read now
Read now
Laura B Hughes, Maria I Danila & S Louis Bridges. (2009) Recent Advances in Personalizing Rheumatoid Arthritis Therapy and Management. Personalized Medicine 6:2, pages 159-170.
Read now
Read now
Y Valle, IY Ledezma-Lozano, N Torres-Carrillo, JR Padilla-Gutiérrez, RE Navarro-Hernández, M Vázquez-Del Mercado, CA Palafox-Sánchez, J Armendáriz-Borunda & JF Muñoz-Valle. (2009) Circulating TNFRI and TNFRII levels correlated with the disease activity score (DAS28) in rheumatoid arthritis. Scandinavian Journal of Rheumatology 38:5, pages 332-335.
Read now
Read now
Articles from other publishers (41)
Kaja Eriksson, Anna Lundmark, Luis F. Delgado, Yue O. O. Hu, Guozhong Fei, Linkiat Lee, Carina Fei, Anca I. Catrina, Leif Jansson, Anders F. Andersson & Tülay Yucel-Lindberg. (2022) Salivary Microbiota and Host-Inflammatory Responses in Periodontitis Affected Individuals With and Without Rheumatoid Arthritis. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Samantha Rodríguez-Muguruza, Antonio Altuna-Coy, Sonia Castro-Oreiro, Maria José Poveda-Elices, Ramon Fontova-Garrofé & Matilde R. Chacón. (2021) A Serum Biomarker Panel of exomiR-451a, exomiR-25-3p and Soluble TWEAK for Early Diagnosis of Rheumatoid Arthritis. Frontiers in Immunology 12.
Crossref
Crossref
Faruk Kiliç, Ümit Işik, Ayşe Usta & Arif Demirdaş. (2021) Serum tumor necrosis factor-like weak inducer of apoptosis levels are elevated in schizophrenia. Brazilian Journal of Psychiatry 43:3, pages 242-246.
Crossref
Crossref
Katsuhito Ihara, Jan Skupien, Bozena Krolewski, Zaipul I. Md Dom, Kristina O’Neil, Eiichiro Satake, Hiroki Kobayashi, Narges M. Rashidi, Monika A. Niewczas & Andrzej S. Krolewski. (2021) A profile of multiple circulating tumor necrosis factor receptors associated with early progressive kidney decline in Type 1 Diabetes is similar to profiles in autoimmune disorders. Kidney International 99:3, pages 725-736.
Crossref
Crossref
K. Sayed, F. Mohammed, R. Abdel Hay, N. Ezzeldin, L. Rashed & A. Fahim. (2019) Elevated serum tumour necrosis factor‐like weak inducer of apoptosis in alopecia areata: a possible marker of disease severity. Clinical and Experimental Dermatology 45:4, pages 426-431.
Crossref
Crossref
Abd El‐Aziz Ibrahim El‐Taweel, Rehab Mohammed Salem, Amira Mohamed Noureldin Abdelrahman & Basma Abd El‐Kafy Mohamed. (2019) Serum TWEAK in acne vulgaris: An unknown soldier. Journal of Cosmetic Dermatology 19:2, pages 514-518.
Crossref
Crossref
Burhan Engin, Ali Tanakol, Huri Bulut, Abdullah Songür, Hayriye E. Vehid, Eral Gökalp, Zekayi Kutlubay, Defne Özkoca, Yalçın Tüzün & Server Serdaroğlu. (2019) Changes in serum TNF‐like weak inducer of apoptosis (TWEAK) levels and Psoriasis Area Severity Index (PASI) scores in plaque psoriasis patients treated with conventional versus anti‐TNF treatments. International Journal of Dermatology 59:2, pages 207-215.
Crossref
Crossref
ANDREA Fischer, MARIELLA BOCKSTAHLER, ANNA-MARIA MÜLLER, VERA STROIKOVA, CHRISTOPH LEIB, GABRIELE PFITZER, HUGO A. KATUS & ZIYA KAYA. (2019) FN14 Signaling Plays a Pathogenic Role in a Mouse Model of Experimental Autoimmune Myocarditis. Journal of Cardiac Failure 25:8, pages 674-685.
Crossref
Crossref
Sung Jun Lee, Jinjoo Kim, JaeSang Ko, Eun Jig Lee, Hyoung Jun Koh & Jin Sook Yoon. (2018) Tumor necrosis factor-like weak inducer of apoptosis induces inflammation in Graves’ orbital fibroblasts. PLOS ONE 13:12, pages e0209583.
Crossref
Crossref
Ines Pombeiro, Sven Loosen, Sanchari Roy, Florian Schueller, Lukas Niewenhuisen, Mark Luedde, Mihael Vucur, Frank Tacke, Marcel Binnebösel, Wenzel Schoening, Christian Trautwein, Tom Luedde, Ulf Neumann & Christoph Roderburg. (2018) Differential Roles of Tumor Necrosis Factor Ligand Superfamily Members as Biomarkers in Pancreatic Cancer. Journal of Clinical Medicine 7:7, pages 175.
Crossref
Crossref
Abdullah Icli, Medine Cumhur Cure, Erkan Cure, Sevket Arslan, Mehmet Unal, Davut Sakiz, Miyase Ozucan, Aysun Toker, Kultigin Turkmen & Adem Kucuk. (2018) Soluble Tumor Necrosis Factor (TNF)-Like Weak Inducer of Apoptosis (Tweak) Independently Predicts Subclinical Atherosclerosis in Behcet’s Disease. Acta Medica (Hradec Kralove, Czech Republic) 61:3, pages 86-92.
Crossref
Crossref
Il-Yeong Hwang, Yoon-Seok Youm, Sung-Do Cho, Seung-Won Choi, Mun-Hee Bae, Seon-Jae Park & Han-Wook Kim. (2018) Synovial fluid levels of TWEAK and matrix metalloproteinase 1 in patients with osteoarthritis, and associations with disease severity. Journal of Orthopaedic Surgery 26:1, pages 230949901876011.
Crossref
Crossref
Yale Liu, Lingling Peng, Liang Li, Chengfei Liu, Xiao Hu, Shengxiang Xiao & Yumin Xia. (2017) TWEAK/Fn14 Activation Contributes to the Pathogenesis of Bullous Pemphigoid. Journal of Investigative Dermatology 137:7, pages 1512-1522.
Crossref
Crossref
Michael Croft & Richard M. Siegel. (2017) Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases. Nature Reviews Rheumatology 13:4, pages 217-233.
Crossref
Crossref
Sandrine Guis, Philippe Berbis, Delphine Stephan, Daniel Bertin, Florent Amatore, Nathalie Balandraud, Nathalie Lesavre & Sophie Desplat-Jégo. (2016) TWEAK-binding autoantibodies are generated during psoriatic arthritis and are not influenced by anti-TNF therapy. Journal of Translational Medicine 14:1.
Crossref
Crossref
Hanna Myśliwiec, Piotr Myśliwiec, Anna Baran & Iwona Flisiak. (2016) Dithranol treatment of plaque-type psoriasis increases serum TNF-like weak inducer of apoptosis (TWEAK). Advances in Medical Sciences 61:2, pages 207-211.
Crossref
Crossref
Christoph Roderburg, Fabian Benz, Florian Schüller, Ines Pombeiro, Hans-Joerg Hippe, Norbert Frey, Christian Trautwein, Tom Luedde, Alexander Koch, Frank Tacke & Mark Luedde. (2016) Serum Levels of TNF Receptor Ligands Are Dysregulated in Sepsis and Predict Mortality in Critically Ill Patients. PLOS ONE 11:4, pages e0153765.
Crossref
Crossref
Mustafa Kaplan, Mahmut Yuksel, Ihsan Ates, Zeki Mesut Yaln Kilic, Hasan Kilic, Hale Ates & Ertugrul Kayacetin. (2016) Are sTWEAK and IL-17A Levels in Inflammatory Bowel Disease Associated with Disease Activity and Etiopathogenesis?. Inflammatory Bowel Diseases 22:3, pages 615-622.
Crossref
Crossref
Wang-Dong Xu, Yi Zhao & Yi Liu. (2015) Role of the TWEAK/Fn14 pathway in autoimmune diseases. Immunologic Research 64:1, pages 44-50.
Crossref
Crossref
Xuyan Niu, Cheng Lu, Cheng Xiao, Na Ge, Miao Jiang, Li Li, Yanqin Bian, Gang Xu, Zhaoxiang Bian, Ge Zhang & Aiping Lu. (2015) The Crosstalk of Pathways Involved in Immune Response Maybe the Shared Molecular Basis of Rheumatoid Arthritis and Type 2 Diabetes. PLOS ONE 10:8, pages e0134990.
Crossref
Crossref
Yan-Ying Du, Yan-Xia Zhao, Yu-Ping Liu, Wei Liu, Ming-Ming Wang & Chong-Ming Yuan. (2015) Regulatory Tweak/Fn14 signaling pathway as a potent target for controlling bone loss. Biomedicine & Pharmacotherapy 70, pages 170-173.
Crossref
Crossref
Frank R. Brennan. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies
969
1078
.
Qing-Lin Peng, Xiao-Ming Shu, Xiao-Lan Tian, Xin Lu & Guo-Chun Wang. (2014) Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis. Arthritis Research & Therapy 16:1, pages R26.
Crossref
Crossref
Mengmeng Li, Tao Chen, Zaipei Guo, Jingyi Li & Na Cao. (2013) Tumor necrosis factor‐like weak inducer of apoptosis and its receptor fibroblast growth factor‐inducible 14 are expressed in urticarial vasculitis. The Journal of Dermatology 40:11, pages 891-895.
Crossref
Crossref
Xuefeng Yin, Leopoldo Luistro, Hua Zhong, Melissa Smith, Tom Nevins, Kathleen Schostack, Holly Hilton, Tai-An Lin, Theresa Truitt, Denise Biondi, Xiaoqian Wang, Kathryn Packman, Jim Rosinski, Windy Berkofsky-Fessler, Jian-Ping Tang, Saumya Pant, David Geho, Suzana Vega-Harring, Mark DeMario, Hy Levitsky & Mary Simcox. (2013) RG7212 Anti-TWEAK mAb Inhibits Tumor Growth through Inhibition of Tumor Cell Proliferation and Survival Signaling and by Enhancing the Host Antitumor Immune Response. Clinical Cancer Research 19:20, pages 5686-5698.
Crossref
Crossref
Harald Wajant. (2013)
The
TWEAK
‐
Fn14
system as a potential drug target
. British Journal of Pharmacology 170:4, pages 748-764.
Crossref
Crossref
Jin-Sil Park, Seung-Ki Kwok, Mi-Ae Lim, Hye-Joa Oh, Eun-Kyung Kim, Joo-Yeon Jhun, Ji Hyeon Ju, Kyung-Su Park, Young-Woo Park, Sung-Hwan Park, Ho-Youn Kim, Young-Gyu Cho & Mi-La Cho. (2013) TWEAK Promotes Osteoclastogenesis in Rheumatoid Arthritis. The American Journal of Pathology 183:3, pages 857-867.
Crossref
Crossref
Xuewu Zhang, Fengchun Zhang, Donghai Wu, Chunde Bao, Ping Zhu, Xiao Zhang, Cibo Huang, DongYi He, Yi Tao, Yongfei Fang, Jieruo Gu, Huaxiang Wu, Lingyun Sun, Xiuyan Yang, Feng Huang, Huji Xu, Dongbao Zhao, Miaojia Zhang, Yi Zheng & Zhanguo Li. (2013) Safety of infliximab therapy in rheumatoid arthritis patients with previous exposure to hepatitis B virus. International Journal of Rheumatic Diseases 16:4, pages 408-412.
Crossref
Crossref
Ayan Lahiri, Pierre Pochard, Laëtitia Le Pottier, Gabriel J. Tobón, Boutahar Bendaoud, Pierre Youinou & Jacques-Olivier Pers. (2012) The complexity of the BAFF TNF-family members: Implications for autoimmunity. Journal of Autoimmunity 39:3, pages 189-198.
Crossref
Crossref
Thanh Nguyen, Joyce Obeid, Hilde E. Ploeger, Tim Takken, Linda Pedder & Brian W. Timmons. (2012) Inflammatory and growth factor response to continuous and intermittent exercise in youth with cystic fibrosis. Journal of Cystic Fibrosis 11:2, pages 108-118.
Crossref
Crossref
Jiro Yamana, Eric F. Morand, Tsuno Manabu, Katsue Sunahori, Kouji Takasugi, Hirofumi Makino & Masahiro Yamamura. (2012) Inhibition of TNF-induced IL-6 by the TWEAK-Fn14 interaction in rheumatoid arthritis fibroblast like synoviocytes. Cellular Immunology 272:2, pages 293-298.
Crossref
Crossref
Linda C. Burkly, Jennifer S. Michaelson & Timothy S. Zheng. (2011) TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses. Immunological Reviews 244:1, pages 99-114.
Crossref
Crossref
T Chen, Z-P Guo, M-M Li, J-Y Li, X-Y Jiao, Y-H Zhang & H-J Liu. (2011) Tumour necrosis factor-like weak inducer of apoptosis (TWEAK), an important mediator of endothelial inflammation, is associated with the pathogenesis of Henoch–Schonlein purpura. Clinical and Experimental Immunology 166:1, pages 64-71.
Crossref
Crossref
Yunying Chen, Sara Lind Enoksson, Catharina Johansson, Maria A. Karlsson, Lena Lundeberg, Gunnar Nilsson, Annika Scheynius & Mikael C. I. Karlsson. (2011) The Expression of BAFF, APRIL and TWEAK Is Altered in Eczema Skin but Not in the Circulation of Atopic and Seborrheic Eczema Patients. PLoS ONE 6:7, pages e22202.
Crossref
Crossref
Sandra Peternel, Teo Manestar-Blažić, Ines Brajac, Larisa Prpić-Massari & Marija Kaštelan. (2011) Expression of TWEAK in normal human skin, dermatitis and epidermal neoplasms: association with proliferation and differentiation of keratinocytes. Journal of Cutaneous Pathology, pages no-no.
Crossref
Crossref
Anak ASSK Dharmapatni, Malcolm D Smith, Tania N Crotti, Christopher A Holding, Cristina Vincent, Helen M Weedon, Andrew CW Zannettino, Timothy S Zheng, David M Findlay, Gerald J Atkins & David R Haynes. (2011) TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis. Arthritis Research & Therapy 13:2.
Crossref
Crossref
Faye N. Hant & Richard M. Silver. (2010) Biomarkers of Scleroderma Lung Disease: Recent Progress. Current Rheumatology Reports 13:1, pages 44-50.
Crossref
Crossref
Axel J. Hueber, Darren L. Asquith, Iain B. McInnes & Ashley M. Miller. (2010) Embracing novel cytokines in RA – complexity grows as does opportunity!. Best Practice & Research Clinical Rheumatology 24:4, pages 479-487.
Crossref
Crossref
N. G. Kataria, P. M. Bartold, A. A. S. K. Dharmapatni, G. J. Atkins, C. A. Holding & D. R. Haynes. (2010) Expression of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 protein (Fn14), in healthy tissues and in tissues affected by periodontitis. Journal of Periodontal Research, pages no-no.
Crossref
Crossref
KOICHI YANABA, AYUMI YOSHIZAKI, EIJI MUROI, TOSHIHIDE HARA, FUMIHIDE OGAWA, AYA USUI, MINORU HASEGAWA, MANABU FUJIMOTO, KAZUHIKO TAKEHARA & SHINICHI SATO. (2009) Elevated Circulating TWEAK Levels in Systemic Sclerosis: Association with Lower Frequency of Pulmonary Fibrosis. The Journal of Rheumatology 36:8, pages 1657-1662.
Crossref
Crossref
Mohit JainAniela JakubowskiLei CuiJianru ShiLihe SuMichael BauerJian GuanChee Chew LimYoshiro NaitoJeffrey S. ThompsonFlora SamChristine AmbroseMichael ParrThomas CrowellJohn M. LincecumMonica Z. WangYen-Ming HsuTimothy S. ZhengJennifer S. MichaelsonRonglih LiaoLinda C. Burkly. (2009) A Novel Role for Tumor Necrosis Factor–Like Weak Inducer of Apoptosis (TWEAK) in the Development of Cardiac Dysfunction and Failure. Circulation 119:15, pages 2058-2068.
Crossref
Crossref